Status:
COMPLETED
Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders
Lead Sponsor:
Boston University Charles River Campus
Conditions:
Alcohol Use Disorder
Anxiety Disorders
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Almost 18 million US adults have alcohol use disorders (AUD), with one third of these individuals also diagnosed with anxiety disorders (AXD). The coexistence of AUD and AXD imposes a high burden via ...
Eligibility Criteria
Inclusion
- DSM-5 diagnosis of an alcohol use disorder (AUD)
- DSM-5 diagnosis of Social Anxiety Disorder (SAD), Panic Disorder/Agoraphobia (PD/A), Generalized Anxiety Disorder (GAD), and/or Obsessive Compulsive Disorder (OCD) as determined by a clinician-administered diagnostic assessment using the Anxiety Disorder Interview Schedule (ADIS) for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); and are rated as crossing the threshold for a formal DSM-5 diagnosis by assignment of an ADIS clinical severity rating (CSR) of 4 (definitely disturbing/disabling on the 0-8 CSR scale) or higher on at least the principal diagnosis.
- Adults 21 years old or older
- Expressed desire to stop drinking alcohol completely or to reduce alcohol consumption
- Reported drinking an average of at least 15 standard drinks per week for males, or 8 for females occurring over a 28-consecutive day period during the 90 day-long time window that preceded the screening session
- Must be willing to discontinue any form of psychotherapy, except Alcoholics Anonymous (AA), that he or she may be receiving for either anxiety or depression prior to screening.
- Exclusion Criteria:
- DSM-5 diagnosis of current major depressive disorder (with the exception of substance-induced depressive disorder) that requires immediate treatment with pharmacologic agents, bipolar disorder, schizophrenia, current bulimia/anorexia, dementia, or other substance dependence, with the exception of nicotine, marijuana, and caffeine dependence.
- Presence of suicidal ideation or history of suicide attempts
- Non-English speakers
- Previously received an adequate trial of cognitive-behavioral therapy (CBT; 8 sessions within the past 5 years)
- Contraindications to MRI scans
- History of head injury with \>5-minute loss of consciousness
- Pregnancy Note: Women of childbearing potential (not postmenopausal for at least one year) will be required to provide a negative urine pregnancy test prior to each scan.
- Implantation of anything containing magnetically sensitive material including metal plates, aneurysm clips, and cardiac pacemakers, stents; history of sheet metal work, claustrophobia
- Cognitive impairment (MOCA\<21).
- Serious medical illness or instability for which hospitalization may be likely within the next year.
Exclusion
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03230006
Start Date
March 1 2018
End Date
January 31 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University, Charles River Campus
Boston, Massachusetts, United States, 02215